Geoffrey M. Parker - 27 Jul 2023 Form 4 Insider Report for Better Therapeutics, Inc.

Role
Director
Signature
/s/ Mark Heinen, Attorney-in-Fact
Issuer symbol
BTTX on OTC
Transactions as of
27 Jul 2023
Net transactions value
+$500,000
Form type
4
Filing time
31 Jul 2023, 07:58:44 UTC
Previous filing
14 Jun 2023
Next filing
16 Oct 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $500,000 +685,025 +200% $0.7299 1,028,055 27 Jul 2023 Direct F1, F2
holding BTTX Common Stock 53,333 27 Jul 2023 By Parker Trust F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 25, 2023, the Issuer entered into a Securities Purchase Agreement with certain investors (the "PIPE Investors") in a private placement offering, pursuant to which the PIPE Investors agreed to purchase shares of Issuer common stock for $0.7299 per share.
F2 As one of the PIPE Investors, the Reporting Person acquired 685,025 shares of Issuer common stock on July 27, 2023 for $0.7299 per share.
F3 These shares are owned directly by the Geoffrey M. Parker and Jill G. Parker Rev Trust dtd 1/27/00 (the "Parker Trust"), and indirectly by the Reporting Person and his spouse, Jill G. Parker, as trustees of the Parker Trust.